Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not recommended during pregnancy, and current guidance advises stopping it before you try to conceive. Based on the medicine's properties, most clinical sources suggest stopping at least four weeks before attempting pregnancy, though your own prescriber or GP may advise a longer gap depending on your full health picture. This is a prescription-only medicine requiring clinical assessment, and decisions about timing should always be made with a healthcare professional who knows your situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no. Tirzepatide has not been studied in human pregnancy, and the available animal data raised enough concern for regulators to conclude that the medicine should not be used during pregnancy at all. That precautionary position extends to the period before conception too, because the medicine needs time to clear your system before you try.
The MHRA is clear on this: women of childbearing potential should use reliable contraception while on tirzepatide. If pregnancy is the goal, that means stopping the medicine first and allowing an adequate gap. For practical guidance on what that gap should be, the Mounjaro treatment page sets out the basics, and the full patient information leaflet published on the eMC carries the manufacturer's specific wording. Your prescriber is the right person to translate that into a personal plan.
It's worth saying plainly: if you're reading this because you've just found out you're pregnant while still on Mounjaro, don't panic. Speak to your GP or midwife as soon as you can. Missing a dose while you arrange that conversation is unlikely to cause harm; continuing the medicine without medical input is the thing to avoid.
Four weeks is the figure most often cited in clinical practice, and it stems from the medicine's pharmacokinetics: tirzepatide has an approximate half-life of around five days, meaning it takes roughly four to five weeks to fall to negligible levels in the body after the last injection, and if you want to understand how long before Mounjaro works so you can weigh up the full treatment timeline before making a decision, our dedicated page covers what to expect at each stage. NHS England's guidance on weight-management injections supports stopping tirzepatide before conception and using that window to transition to appropriate preconception care.
That said, four weeks is a floor, not a guarantee. Some clinicians advise a longer gap, particularly if you've been at a higher maintenance dose for some time, or if you have other health conditions that a pregnancy would affect. Stopping Mounjaro also means thinking about what comes next for your weight management — stopping abruptly without a plan can lead to weight regain, and changes in weight carry their own implications for fertility and pregnancy outcomes. The guidance on stopping Mounjaro safely covers that transition in more detail.
There is one further practical point. If you've been relying on the oral contraceptive pill while on tirzepatide, you should know that the pill's absorption can be reduced during the first four weeks of each new dose (or dose increase), because the medicine slows gastric emptying. This doesn't affect every method of contraception, only ones that depend on oral absorption. A prescriber can help you choose a method that's reliable during your treatment period and your planned stop window.
Your GP, a fertility specialist, or the prescriber who manages your Mounjaro treatment (ideally all three talking to each other) are the people best placed to set a stop date and a preconception plan. There's no one-size answer because your weight history, any comorbidities, your menstrual cycle, and your fertility picture all feed into it.
Some useful questions to raise: Should I taper the dose before stopping, or stop from my current dose? Is four weeks the right gap for my dose and health situation, or do you recommend longer? What weight management approach do you suggest during the gap and through pregnancy itself? Are there any supplements or lifestyle adjustments I should prioritise in the meantime?
Our clinical team is available to discuss what stopping Mounjaro means for your situation, and our prescribers review every case individually. For anyone currently on treatment through nume who is planning a pregnancy, speaking to our team before your next repeat order is the right first step. You can also explore general information about weight-loss treatments available through a clinical consultation for context on what options exist once you're ready to return to treatment after pregnancy.
If you haven't yet started Mounjaro and are wondering whether it's right for you given future pregnancy plans, reviewing how long it typically takes before you lose weight on Mounjaro may help you think through the timing. A prescriber can factor your plans into the assessment from the outset. If you are also due to have a procedure in the near future, it is worth reading about how long before surgery you should stop Mounjaro, and our dedicated page on how long to stop Mounjaro before surgery sets out the clinical reasoning in full.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.